These results support the development of tau PET imaging as a diagnostic approach for various tauopathies that will aide us in better understanding the pathophysiology underlying tauopathies, in combination with other tracers and clinical tests, and may serve as a biomarker to follow treatment efficacy. This evidence concerns the gene MAPT and tauopathy.